Assyro AI

FDA Orange Book · active-ingredient family

Sodium nitrite; sodium thiosulfate

Sodium nitrite; sodium thiosulfate is approved in 1 FDA application, with therapeutic-equivalence codes, listed patents, and marketing exclusivity from the FDA Orange Book.

Reference-listed drug:NITHIODOTE · NDA 201444

1

Brand (NDA)

0

Generics (ANDA)

8

Listed patents

0

Exclusivity periods

Brand (NDA) products · solution, solution

ProductApplicantApplicationTEApproved
NITHIODOTERLDHOPE PHARMSNDA 201444Jan 14, 2011

Listed patents (8)

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
PatentExpiresInType
11753301Feb 10, 2030in 3 yr 8 mo
SubstanceProductU-3681
9687506Feb 10, 2030in 3 yr 8 mo
ProductU-3394
12304813Feb 10, 2030in 3 yr 8 mo
Product
9345724Jul 07, 2030in 4 yr 1 mo
SubstanceProductU-2015
10479686Jul 07, 2030in 4 yr 1 mo
ProductU-3390
9585912Jul 07, 2030in 4 yr 1 mo
SubstanceProduct
8496973Mar 29, 2031in 4 yr 10 mo
SubstanceProductU-1419
8568793Dec 24, 2031in 5 yr 7 mo
SubstanceProduct

Sodium nitrite; sodium thiosulfate — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.